Press Release
Press Release
RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage
Read Full Story
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release